Page 1 of Clinical Trials for Drug SRT2104, 13 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
Last Updated: February 16, 2012
Condition(s): Psoriasis
2
Withdrawn
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
Last Updated: April 29, 2011
Condition(s): Healthy Volunteer; Atrophy, Muscular
3
Recruiting
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
Last Updated: April 5, 2012
Condition(s): Colitis, Ulcerative
4
Completed
A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus
Last Updated: March 29, 2012
Condition(s): Diabetes Mellitus, Type 2
5
Completed
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
Last Updated: December 9, 2010
Condition(s): Healthy Volunteer; Atrophy, Muscular
6
Completed
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus
Last Updated: January 5, 2012
Condition(s): Diabetes Mellitus, Type 2
7
Completed
Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers
Last Updated: February 17, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Healthy Volunteer
8
Completed
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
9
Completed
Effect of SRT2104 on Endotoxin-induced Inflammation
Last Updated: February 17, 2011
Condition(s): Sepsis
10
Completed
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
Last Updated: February 17, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
11
Completed
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer
12
Completed
Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Last Updated: December 1, 2011
Condition(s): Diabetes Mellitus, Type 2
13
Completed
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers
Last Updated: August 4, 2011
Condition(s): Diabetes Mellitus, Type 2; Healthy Volunteer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+SRT2104

Page 1 of Clinical Trials for Drug SRT2104, 13 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About